Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
#Veterinary Oncology Market Expansion Outlook: What Revenue Opportunities Are Ahead?#_x000D_
The veterinary oncology market size has seen rapid growth in recent years. It is anticipated to expand from $0.45 billion in 2025 to $0.5 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 11.0%. The growth observed in the preceding period can be linked to a rising occurrence of cancer in companion animals, increasing recognition of veterinary oncology services, advancements in technology for surgical and radiology equipment, the expansion of veterinary hospitals and specialty clinics, and the adoption of conventional chemotherapy treatments._x000D_
_x000D_
The veterinary oncology market is poised for significant expansion in the upcoming years. Its valuation is projected to reach $0.77 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 11.3%. This projected growth is driven by several factors, including an escalating demand for personalized and targeted therapies, the wider adoption of advanced radiology and imaging techniques, the increasing application of immunotherapy and supportive care, ongoing developments in minimally invasive surgical procedures, and the integration of combined chemotherapy and targeted therapy protocols. Key trends during this period will involve the ongoing expansion of personalized and targeted veterinary cancer treatments, further advancements in minimally invasive surgical techniques, the greater embrace of sophisticated radiology and imaging technologies, the evolution of new combination chemotherapy protocols, and the incorporation of immunotherapy and supportive care into comprehensive treatment plans._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Veterinary Oncology Market Demand Drivers Opening New Revenue Streams#_x000D_
The increasing occurrence of cancer in companion animals is anticipated to drive growth in the veterinary oncology market. Cancer is characterized by uncontrolled cell growth spreading within the body, with pet cancer manifesting as physical tumors like swelling. Veterinary oncology specializes in diagnosing and treating cancer in animals, aiming to limit metastasis and disease progression. Consequently, a rise in pet cancer cases will elevate the demand for veterinary oncology services. For example, The Cancer Letter, a US-based publication on cancer research, reported an estimated 6 million pet dogs would be diagnosed with cancer in the United States in 2024. Additionally, the British Small Animal Veterinary Association (BSAVA), a UK-based veterinary community, indicated in November 2023 that approximately 1 in 4 dogs and 1 in 5 cats are expected to develop cancer during their lives. Thus, the rising incidence of cancer in pets is fueling the veterinary oncology market._x000D_
_x000D_
#Veterinary Oncology Market Segments: Where Is Growth Concentrated?#_x000D_
The veterinary oncology market covered in this report is segmented – _x000D_
_x000D_
1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies _x000D_
2) By Animal Type: Equine, Canine, Feline, Other Animal Types_x000D_
3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types_x000D_
_x000D_
Subsegments:_x000D_
1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation_x000D_
2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques_x000D_
3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents_x000D_
4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies_x000D_
_x000D_
#Veterinary Oncology Market Trends Powering Strategic Industry Growth#_x000D_
Leading companies within the veterinary oncology market are prioritizing the development of neoantigens, which are specific tumor antigens resulting from mutations in cancer cells. These are unique protein fragments that emerge from tumor-specific genetic changes within malignant cells. Unlike regular antigens found in healthy tissues, neoantigens are created as a direct consequence of genetic alterations (mutations) within the tumor’s DNA. For instance, in October 2024, Biotechnology company, a US-based company, launched a cancer vaccine trial for dogs. Neoantigens are currently being investigated for their potential in developing cancer vaccines and other immunotherapies, with the objective of specifically enhancing the immune response against cancer cells while preserving normal cells._x000D_
_x000D_
#Veterinary Oncology Market Leading Players And Competitive Positioning#_x000D_
Major companies operating in the veterinary oncology market are PetCure Oncology Inc., Zoetis Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, AB Science SAS, Pfizer Inc., Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, ZENOAQ GmbH, Oncovet Clinical Research Inc. _x000D_
_x000D_
#View The Full Veterinary Oncology Market Report:#_x000D_
_x000D_
#Veterinary Oncology Market Regional Split: Which Areas Are Fueling Growth?#_x000D_
Asia-Pacific was the largest region in the veterinary oncology market in 2025. North America is expected to be the fastest-growing region in the veterinary oncology market report during the forecast period. The regions covered in the veterinary oncology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
